2 reports

Gene Therapy in CVMD

7012 7995 6236
  • Overview of the Development Pipeline for CVMD Gene Therapy
  • Products in Clinical Development for CVMD Gene Therapy

I think one collapsed in Phase I and one in Phase II.

  • Gene Therapy
  • Therapy
  • AnGes MG, Inc.
  • Juventas Therapeutics, Inc.
  • ViroMed Co., Ltd.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Product Development Milestones

HGF plasmid has the potential to be one of the first gene therapy products to be approved for a non-genetic disease with chronic conditions.

  • Cell Therapy
  • Gene Therapy
  • Regenerative Medicine
  • Therapy
  • AnGes MG, Inc.